We also demonstrated that induced Th2 immune responses, which mimic an atopic dermatitis-like phenotype, can lead to successful viral penetration as shown by infected cells in interleukin-4 (IL-4)/IL-13-treated human skin (14). This evidence concerns the gene IL13 and atopic eczema.